We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
-14.59%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$70.1B
AUM Growth
-$16.1B
(-19%)
Cap. Flow
-$2.27B
Cap. Flow
% of AUM
-3.24%
Top 10 Holdings %
Top 10 Hldgs %
16.75%
Holding
1,919
New
109
Increased
944
Reduced
712
Closed
131
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Energy Transfer Partners
ET
|
+$803M |
| 2 |
Alibaba
BABA
|
+$375M |
| 3 |
Nektar Therapeutics
NKTR
|
+$213M |
| 4 |
Meta Platforms (Facebook)
META
|
+$209M |
| 5 |
SLB Ltd
SLB
|
+$198M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ETP
Energy Transfer Partners, L.P.
ETP
|
+$1.01B |
| 2 |
New Oriental
EDU
|
+$317M |
| 3 |
Comcast
CMCSA
|
+$241M |
| 4 |
Intercontinental Exchange
ICE
|
+$238M |
| 5 |
DaVita
DVA
|
+$203M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.28% |
| 2 | Technology | 14.55% |
| 3 | Healthcare | 13.72% |
| 4 | Energy | 13.45% |
| 5 | Financials | 13.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Grupo Aval
AVAL
$5.67B
| $187M | 0.27% |
31,645,261
-6,280
| -0% | -$43.1K |
|
|
EXAS
102
DELISTED
Exact Sciences
EXAS
| $181M | 0.26% |
2,865,233
-1,659,165
| -37% | -$114M |
|
|
HEP
103
DELISTED
Holly Energy Partners, L.P.
HEP
| $179M | 0.26% |
6,267,063
-218,299
| -3% | -$6.45M |
|
104
CME Group
CME
$92.2B
| $176M | 0.25% |
934,795
-815,363
| -47% | -$151M |
|
105
Boeing
BA
$165B
| $175M | 0.25% |
543,779
+12,873
| +2% | +$4.45M |
|
106
NGL Energy Partners
NGL
$1.94B
| $173M | 0.25% |
17,992,787
+466,852
| +3% | +$4.78M |
|
107
Ulta Beauty
ULTA
$20.4B
| $168M | 0.24% |
684,279
+196,597
| +40% | +$54.3M |
|
108
Bank of America
BAC
$435B
| $166M | 0.24% |
6,747,773
-1,235,573
| -15% | -$33.5M |
|
109
EPAM Systems
EPAM
$4.69B
| $164M | 0.23% |
1,415,408
-7,619
| -0.5% | -$935K |
|
110
Abbott
ABT
$180B
| $164M | 0.23% |
2,263,567
-15,750
| -0.7% | -$1.11M |
|
111
Centene
CNC
$31.3B
| $163M | 0.23% |
2,828,674
-32,502
| -1% | -$2.18M |
|
112
AT&T
T
$165B
| $163M | 0.23% |
7,547,756
-1,078,730
| -13% | -$25.1M |
|
113
Ecolab
ECL
$75.6B
| $162M | 0.23% |
1,100,156
+1,936
| +0.2% | +$296K |
|
114
Eastman Chemical
EMN
$7.8B
| $162M | 0.23% |
2,217,041
-150,053
| -6% | -$12M |
|
|
115
SLB Ltd
SLB
$77.8B
| $161M | 0.23% |
4,448,673
+4,011,200
| +917% | +$198M |
|
116
Equifax
EFX
$20.3B
| $160M | 0.23% |
1,721,911
+549,508
| +47% | +$58.5M |
|
|
STI
117
DELISTED
SunTrust Banks, Inc.
STI
| $153M | 0.22% |
3,042,160
-464,289
| -13% | -$27.8M |
|
118
Salesforce
CRM
$134B
| $152M | 0.22% |
1,108,977
-62,867
| -5% | -$8.65M |
|
|
OPLN
119
Openlane
OPLN
$4.17B
| $147M | 0.21% |
8,157,244
-558,915
| -6% | -$11.6M |
|
120
Westlake Chemical Partners
WLKP
$777M
| $146M | 0.21% |
6,047,866
+332,954
| +6% | +$7.69M |
|
|
LOXO
121
DELISTED
Loxo Oncology, Inc
LOXO
| $142M | 0.2% |
1,014,058
-3,275
| -0.3% | -$497K |
|
|
SAGE
122
DELISTED
Sage Therapeutics
SAGE
| $138M | 0.2% |
1,438,424
-145,196
| -9% | -$16.6M |
|
|
MRSH
123
Marsh
MRSH
$86.3B
| $138M | 0.2% |
1,727,200
-1,529,727
| -47% | -$128M |
|
|
SAVE
124
DELISTED
Spirit Airlines, Inc.
SAVE
| $137M | 0.2% |
2,367,361
-1,668,051
| -41% | -$89.4M |
|
|
SMC
125
Summit Midstream
SMC
$421M
| $135M | 0.19% |
898,591
+249,825
| +39% | +$52.1M |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q4 2018 Portfolio in Review
As of Q4 2018, OppenheimerFunds held 1,919 positions worth $70.1B, down 19% from $86.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
OppenheimerFunds withdrew a net $2.27B in Q4 2018, closing 131 positions and reducing 712 holdings. Its most notable exit was Energy Transfer Partners, L.P., an estimated $1.01B position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
Against the trend, OppenheimerFunds opened a new position in Caesars Entertainment Corporation worth $68.1M.
- OppenheimerFunds's largest Q4 2018 buy was Caesars Entertainment Corporation: 10,035,079 shares worth $68.1M.
- OppenheimerFunds added most to Energy Transfer Partners in Q4 2018, an estimated $803M increase.
- OppenheimerFunds's biggest Q4 2018 reduction was New Oriental, cutting an estimated $317M.
- OppenheimerFunds fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $1.01B.
- OppenheimerFunds's ten largest holdings make up 17% of its $70.1B portfolio in Q4 2018.
- OppenheimerFunds opened 109 new positions and closed 131 in Q4 2018.
- OppenheimerFunds's portfolio value fell 19% quarter-over-quarter to $70.1B.
Based on OppenheimerFunds's 13F filing for Q4 2018, filed 11 Feb 2019.